Transcatheter aortic-valve implantation (TAVI) is associated with procedure-related stroke. Cerebral embolic protection (CEP) devices may reduce embolization to the cerebral circulation and hence ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...

The cardiovascular safety of oral semaglutide, a glucagon-like peptide 1 receptor agonist, has been established in persons with type 2 diabetes and high cardiovascular risk. An assessment of the ...

The primary mission of medical schools is to train physicians who will provide excellent patient care. Pass/fail grading systems, in their current form, could threaten that goal.

Residency applicants have long been advised to play it safe in their personal statement, but what if the best way to rise above the heap is to share a part of yourself you’ve been told to keep ...

Most U.S. medical school applicants now log many hours shadowing physicians to boost their chances of admission, but these experiences may not be beneficial, they have costs, and access to them is ...

For patients with ER-positive, HER2-negative breast cancer, current therapies have several disadvantages, including limited efficacy in patients with ESR1 mutations. New research findings are ...

A reversible interaction between bempedoic acid and fenofibrate leading to a major, reversible decrease in HDL cholesterol levels was found in patients treated for nongenetic elevated LDL ...

Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...

Even as hospitals in Gaza were turned into battlefields, some Palestinian–Israeli health care programs bridged the deep divides and continued to build trust between the populations in conflict.

For patients with IgG4-related disease, there are no approved therapies. New research findings on the efficacy and safety of inebilizumab ― a monoclonal antibody that targets and depletes CD19 ...

Tezepelumab is an epithelial cytokine blocker used to treat severe asthma; its efficacy and safety in patients with chronic rhinosinusitis with nasal polyps have been unclear. New research ...